News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Daily News After EXCEL and NOBLE, New Meta-analysis Revisits PCI vs Surgery for Unprotected Left Main CAD Michael O'Riordan December 14, 2016
News Daily News Noncardiac Surgery May Be Safe Earlier After PCI Than Previously Thought L.A. McKeown December 12, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2016 Shelley Wood November 30, 2016
News Industry News Micell Technologies Announces First Patient Enrolled In Landmark Registration Trial of MiStent In Japan November 29, 2016
News Conference News TCT 2016 RIBS VI: Absorb BVS Safe in In-Stent Restenosis but Fails to Best Xience Metallic Stent Michael O'Riordan November 08, 2016
News Conference News TCT 2016 No Scares From SCAAR: Stent Thrombosis Rates in Newest DES Are Similar—and Low Shelley Wood November 07, 2016
News Industry News Positive Five-Year Clinical Data from Micell Technologies’ MiStent Presented at TCT 2016 November 03, 2016
News Industry News TCT 2016 Imaging Study Shows Rate of Strut Coverage and Low Rates of Neouatherosclerosis with Thin Strut Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents November 02, 2016
News Conference News TCT 2016 TRANSFORM-OCT: Similar Early and Late Healing With Bioresorbable- and Durable-Polymer DES Michael O'Riordan November 02, 2016
Presentation TCT 2016 TRANSFORM-OCT: A Prospective, Randomized Trial Using OCT Imaging to Evaluate Strut Coverage at Three Months and Neoatherosclerosis at Eighteen Months in Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents Presenter: Gary S. Mintz, Robert-Jan van Geuns, Giulio Guagliumi November 02, 2016
Presentation TCT 2016 Highlights (and my Interpretations) From: PLATINUM DIVERSITY Presenter: Philip M. Urban, Stephen G. Worthley, Bonnie H. Weiner November 01, 2016
Presentation TCT 2016 Highlights (and My Interpretations) From: Absorb BVS - ABSORB II and ABSORB China (2-3 Year Results) Presenter: Philip M. Urban, Stephen G. Worthley, Stephen G. Ellis November 01, 2016
Presentation TCT 2016 Highlights (and my Interpretations) From: New BRS - FANTOM II, MeRes-1, FORTITUDE and FUTURE-I (6-9 Month Results) Presenter: Philip M. Urban, Stephen G. Worthley, Robert-Jan van Geuns November 01, 2016
Presentation TCT 2016 Bare Metal and 1st Generation Drug-Eluting Stents: Devices, Indications, and Outcomes Presenter: Dmitriy N. Feldman, Emmanouil S. Brilakis November 01, 2016
Presentation TCT 2016 Highlights (And my Interpretations) From: Polymer-free DES - LEADERS-free 2-year and RevElution Presenter: Philip M. Urban, Stephen G. Worthley, Christian M. Spaulding November 01, 2016
Presentation TCT 2016 Highlights (And my Interpretations) From: DES Comparisons BIO-RESORT (TWENTE III) and BIONICS Presenter: Philip M. Urban, Stephen G. Worthley, Sigmund Silber November 01, 2016
Presentation TCT 2016 TCT 313: Incidence and Predictors of Very Late Major Adverse Cardiac Events After Metallic Stents: A Patient-Level Pooled Analysis from Seventeen Randomized Trials Presenter: Serban Puricel, Clemens von Birgelen November 01, 2016
Presentation TCT 2016 TCT 263: Impact of Diabetes on Clinical Outcomes in Patients Undergoing Unprotected Left Main Percutaneous Coronary Intervention with Drug-Eluting Stents Presenter: Kevin J. Beatt, Frederick Feit October 31, 2016
Presentation TCT 2016 Self-Expanding Stentys Stent In Various Anatomic Subsets: Evidence Of Clinical Benefit? Presenter: Chaim S. Lotan, Giora Weisz, Francesco Prati October 31, 2016